Polymeric adhesive matrix with salified carboxylic groups for transdermal use
Polymeric matrices for the controlled release of medicaments for the topical transdermal use comprising copolymers of acrylic and/or methacrylic acid or esters thereof having a Tg lower than 0° C., whose free carboxy groups are salified with compatible organic or inorganic bases. The matrices of the invention allow to prepare therapeutical systems for the controlled-release of active principles through the transdermal route, thus solving stability, solubility and/or bioavailability problems of the active ingredient within the matrix.
1. Topical transdermal controlled release systems of medicaments consisting of:
diclofenac as medicament;
a polymeric matrix for said controlled release of said medicaments, said polymeric matrix consisting of copolymers of poly(2-ethyl-hexyl acrylate-co-acrylic acid-co-methyl acrylates) having a Tg lower than 0° C.,
wherein the free carboxylic groups are salified with stoichiometric amounts of amino methyl-acrylate copolymers.
2. The system as claimed in claim 1 , wherein the poly(2-ethyl-hexyl acrylate-co-acrylic acid-co-methyl acrylates) copolymers have a percentage of free carboxy groups ranging from 0.1 to 15%.
3. The system as claimed in claim 2 wherein the poly(2-ethyl-hexyl acrylate-co-acrylic acid-co-methyl acrylates) copolymers have a percentage of free carboxy groups ranging from 1 to 10%.
4. Topical transdermal controlled release systems of medicaments consisting of:
diclofenac as medicament;
0.1 to 20% by weight of water, and
a polymeric matrix for said controlled release of said medicaments, said polymeric matrix consisting of copolymers of poly(2-ethyl-hexyl acrylate-co-acrylic acid-co-methyl acrylates) having a Tg lower than 0° C.,
wherein the free carboxylic groups are salified with stoichiometric amounts of amino methyl-acrylate copolymers.
5. The system as claimed in claim 4 , wherein water is present in an amount of between 1 to 5% by weight.
6. A transdermal patch comprising as an adhesive layer a composition according to claim 1 .
7. A process for the preparation of a topical transdermal controlled release systems of medicaments which comprises the treatment-of the copolymer of claim 1 having a Tg lower than 0° C. and free carboxy groups suspended in an organic solvent with an aqueous solution of amino methyl acrylate copolymers in stoichiometric amounts with respect to the carboxylic groups, followed by addition of an active ingredient and any other excipients, wherein said active ingredient is diclofenac.